Psychedelics Billionaire Steve Cohen’s Point 72 hedge fund takes 8.1% stake in Cybin It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety Rowan DunneSeptember 19, 2023
Canada Vancouver Island University to launch Canada’s first psychedelic-assisted therapy graduate program 'Psychedelic-assisted therapy will be an integral part of mental wellness therapeutic models in the very near future,' says one of the program's coordinators Natalia Buendia CalvilloFebruary 14, 2022
Psychedelics 2020’s top 5 advancements in psychedelics With major research, legal reform, and more than 20 firms going public, it was major year for the re-emerging field Jared GnamDecember 30, 2020
Medical and Pharmaceutical Canada could regulate psychedelic therapy within few years, bets company Numinus Wellness goes public on the prediction that regulation is coming Michelle GamageMay 22, 2020
Cannabis 2.0 Hang tight, better times are coming: Lift & Co expo day 1 The three-day convention kicked off on a positive note at the business conference Michelle GamageJanuary 9, 2020